0001209191-23-042247.txt : 20230713
0001209191-23-042247.hdr.sgml : 20230713
20230713202820
ACCESSION NUMBER: 0001209191-23-042247
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230711
FILED AS OF DATE: 20230713
DATE AS OF CHANGE: 20230713
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Henderson Jeffrey William
CENTRAL INDEX KEY: 0001324015
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 231087796
MAIL ADDRESS:
STREET 1: 7000 CARDINAL PLACE
CITY: DUBLIN
STATE: OH
ZIP: 43017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-07-11
0
0000921299
FIBROGEN INC
FGEN
0001324015
Henderson Jeffrey William
C/O FIBROGEN, INC.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
1
0
0
0
1
Common Stock
2023-07-11
4
S
0
2000
2.69
D
32866
D
Shares sold by the reporting person pursuant to a 10b5-1 trading plan.
Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.66 to $2.735. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-07-13